The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy
Authors:
- 3 February 2023
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 46 (3) , 121-128
Abstract
Signaling pathways play significant roles in the occurrence, development, and treatment of pancreatic cancer (PC). The main treatment options are surgery, chemotherapy, radiotherapy, arterial infusion chemotherapy in interventional therapy, and immunotherapy. Many studies have shown that signaling pathways perform a function in the occurrence and development of PC, for instance, phosphoinositide 3-kinase (PI3K)/AKT, nuclear factor-κB, Ras, interleukin (IL)-17B/IL-17RB, Wnt, and hepatocyte growth factor/c-MET, which play roles in the proliferation, metastasis, invasion, inhibition of apoptosis, promotion of angiogenesis, and drug resistance of PC. Interaction of signaling pathways has an impact on the biological behavior of PC; for example, activation of the neurotensin/NTSR1 pathway, which can activate mitogen-activated protein kinase, nuclear factor-κB, and other pathways related to PC stem cells, play an important role in PC, and an increase in their number is associated with the Wnt/β-catenin and PI3K pathways. Chemotherapy is the main method for the treatment of PC, but drug resistance limits its use. In addition, abnormal activation of IL-17B/IL-17RB signaling pathway is associated with drug resistance. This article discusses the signaling pathways that play different roles in the occurrence and development of PC, as well as current research on signaling pathways in PC treatment.Keywords
This publication has 43 references indexed in Scilit:
- MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic CancerCancer Cell, 2017
- Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic CancerCurrent Medicinal Chemistry, 2017
- Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancerInternational Journal of Oncology, 2017
- Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathwayMolecular Cancer, 2017
- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascadeCancer Letters, 2016
- Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibitionMolecular Cancer, 2016
- Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cellsOncotarget, 2015
- The Key Role of Calmodulin in KRAS-Driven AdenocarcinomasMolecular Cancer Research, 2015
- Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokinesJournal of Experimental Medicine, 2015
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28Pharmacology & Therapeutics, 2015